Anti-Arrhythmic Agents
Showing 1 - 25 of >10,000
Atrial Fibrillation New Onset Trial (Amiodarone Hydrochloride 200 MG)
Not yet recruiting
- Atrial Fibrillation New Onset
- Amiodarone Hydrochloride 200 MG
- (no location specified)
Apr 23, 2023
Stroke, Medication Adherence Trial in Kumasi (Polycap)
Not yet recruiting
- Stroke
- Medication Adherence
-
Kumasi, GhanaKwame Nkrumah Institute of Science & Technology
Jul 19, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Atrial Fibrillation Trial in Falls Church (No Amiodarone)
Terminated
- Atrial Fibrillation
- No Amiodarone
-
Falls Church, VirginiaInova Fairfax Hospital
Jan 5, 2022
Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)
Not yet recruiting
- Relapsed/Refractory Non-Hodgkin Lymphoma
-
Duarte, California
- +1 more
Oct 13, 2023
Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and
Not yet recruiting
- Disability or Chronic Disease Leading to Disablement
- +2 more
- Surgical flap and anti-bacterial agents
-
Garches, FranceDepartment of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
Atrial Fibrillation, Persistent, Arrhythmias, Cardiac Trial in Shanghai (Antiarrhythmic drug including Propafenone, Sotalol,
Not yet recruiting
- Atrial Fibrillation, Persistent
- Arrhythmias, Cardiac
- Antiarrhythmic drug including Propafenone, Sotalol, Dronedarone and Amiodarone
- cryoballoon ablation
-
Shanghai, ChinaRuijin Hospital
Jul 28, 2021
Atherosclerosis, Adherence, Medication, Tolerance Trial in Kumasi (Polycap)
Completed
- Atherosclerosis
- +2 more
-
Kumasi, GhanaKwame Nkrumah University of Science & Technology
Sep 29, 2022
Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)
Completed
- Crohn's Disease
- Ulcerative Colitis
- Immuno monitoring
-
Montpellier, FranceUniversity hospital
Dec 13, 2022
IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)
Not yet recruiting
- Inflammatory Bowel Diseases
- Biological Substance; Adverse Effect
- Azithromycin Pill
- Placebo
-
Haifa, IsraelRambam Health Care Campus
Oct 25, 2022
Risk of NSAIDs on Anastomotic Leak for Rectal Surgery
Recruiting
- Anastomotic Leak
- Anti-Inflammatory Agents, Non-Steroidal
-
Chongqing, None Selected, ChinaArmy Medical Center
Nov 24, 2023
Tumors Trial run by the NCI (Nilotinib and Paclitaxel)
Recruiting
- Neoplasms
- Nilotinib and Paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Fibrillation, Persistent Trial in Canada (Cryoballoon-based PVI,
Active, not recruiting
- Atrial Fibrillation
- +12 more
- Cryoballoon-based PVI
- Anti-Arrhythmic Drug Therapy
-
Calgary, Alberta, Canada
- +17 more
Aug 22, 2022
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022
Executive Function Trial in Chapel Hill (Theta-frequency near-zero phase lag stimulation, Theta-frequency anti-synchrony
Recruiting
- Executive Function
- Theta-frequency near-zero phase lag stimulation
- +5 more
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Feb 18, 2022
PTSD, Alcohol Use Disorder Trial in Baltimore (Pregabalin plus BBCET, Placebo plus BBCET)
Active, not recruiting
- PTSD
- Alcohol Use Disorder
- Pregabalin plus BBCET
- Placebo plus BBCET
-
Baltimore, MarylandUniversity of Maryland School of Medicine
Mar 25, 2022
Clinical Trials of Investigational or Licensed Vaccines or
Recruiting
- Vaccines
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022